市場調查報告書
商品編碼
949445

細胞毒性藥的全球市場:2020-2026年

Global Cytotoxic Drugs Market 2020-2026

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

預計在預測期內,全球細胞毒性藥物市場將緩慢增長。癌症患病率上升是市場增長的主要因素。2018年全球報告的新癌症發病率為1810萬。就2018年的新癌症發病率而言,肺癌和女性乳腺癌是世界領先的癌症類型。在2018年,這些癌症約佔210萬例確診病例,約佔新癌症發病率的11.6%。細胞毒性藥物被認為是不可切除的晚期非小細胞肺癌(NSCLC)的一線治療。

本報告提供全球細胞毒性藥市場相關調查分析,提供市場概要,市場成長的影響要素,市場規模與預測,各市場區隔的市場分析,各地各國的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 報告概要

第2章 市場概要及考察

  • 調查範圍
  • 分析師的考察&目前市場趨勢
  • 開發平台分析
  • 法律規則

第3章 競爭情形

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析
    • Pfizer Inc.
    • Mylan N.V.
    • Johnson & Johnson Services, Inc.
    • F. Hoffman La-Roche AG
    • Bristol Myers Squibb Co.

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 機會

第5章 市場區隔

  • 全球細胞毒性藥市場:各類藥物
    • 烷化劑
    • 代謝拮抗劑
    • 抗腫瘤抗生素
    • 植物生物鹼
    • 其他
  • 全球細胞毒性藥市場:各用途
    • 肺癌
    • 乳癌
    • 前列腺癌
    • 胰臟癌
    • 其他

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • Bristol Myers Squibb Co.
  • Cipla Ltd.
  • Daiichi Sankyo Company, Ltd.
  • Eli Lilly and Co.
  • F. Hoffman La-Roche AG
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Lonza Group Ltd.
  • Lupin Ltd.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
目錄
Product Code: OMR2021764

Global Cytotoxic Drugs Market Size, Share & Trends Analysis Report, By Drug Class (Alkylating, Antimetabolites, Antitumor Antibiotics, Plant Alkaloids, and Others), By Application (Lung Cancer, Breast Cancer, Prostate Cancer, Cytotoxic, and Others) and Forecast, 2020-2026

The global cytotoxic market is estimated to witness sluggish growth during the forecast period. Increasing prevalence of cancer is primarily contributing to the growth of the market. There were 18.1 million new cancer incidences reported globally in 2018. Lung and female breast cancers are the major kinds of cancer globally in terms of the new cancer incidences in 2018. Each of these cancers accounted for nearly 2.1 million diagnoses in 2018, which is nearly 11.6% of the total new cancer incidences. Cytotoxic drugs are regarded as the first-line treatment for unresectable advanced non-small-cell lung carcinoma (NSCLC). These anti-cancer agents travel through the bloodstream and reach several parts of the body. Significant demand for chemotherapy has led the adoption of cytotoxic drugs as these agents act to destroy cancer cells. They treat cells that have broken away from the lung tumor and spread to other parts of the body.

Geographically, the market is classified into four major regions, including North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2019, North America is anticipated to hold a significant share in the market owing to the significant rise in new cancer incidences and rising demand for chemotherapy in the region. The presence of some crucial players such as Johnson & Johnson Services, Inc. and Pfizer Inc. is further contributing to the market growth in the region. Asia-Pacific is estimated to witness considerable growth during the forecast period owing to the rising cancer incidences and emerging awareness regarding cancer diseases in the region.

Some crucial players in the market include Pfizer Inc., Mylan N.V., Johnson & Johnson Services, Inc., F. Hoffman La-Roche AG, and Bristol Myers Squibb Co. Mergers and acquisitions, product launches, and partnerships and collaborations are considered as crucial strategies adopted by the market players. For instance, in February 2019, Eli Lilly and Company acquired Loxo Oncology, Inc. to widen the scope of oncology portfolio of Lilly into precision medicines with the addition of a pipeline of highly selective effective medications for patients suffering from genomically defined cancers. This will enable the company to target cancers that are caused by specific gene abnormalities.

Research Methodology

The market study of the global cytotoxic drugs market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Cytotoxic Drugs Market Research and Analysis by Drug Class

2. Global Cytotoxic Drugs Market Research and Analysis by Application

The Report Covers:

  • Comprehensive research methodology of the global cytotoxic drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global cytotoxic drugs market.
  • Insights about market determinants, which are stimulating the global cytotoxic drugs market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Pipeline Analysis
  • 2.4. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Pfizer Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Mylan N.V.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Johnson & Johnson Services, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. F. Hoffman La-Roche AG
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Bristol Myers Squibb Co.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Cytotoxic Drugs Market by Drug Class
    • 5.1.1. Alkylating
    • 5.1.2. Antimetabolites
    • 5.1.3. Antitumor Antibiotics
    • 5.1.4. Plant Alkaloids
    • 5.1.5. Others
  • 5.2. Global Cytotoxic Drugs Market by Application
    • 5.2.1. Lung Cancer
    • 5.2.2. Breast Cancer
    • 5.2.3. Prostate Cancer
    • 5.2.4. Pancreatic Cancer
    • 5.2.5. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. AbbVie Inc.
  • 7.2. Amgen Inc.
  • 7.3. Bayer AG
  • 7.4. Bristol Myers Squibb Co.
  • 7.5. Cipla Ltd.
  • 7.6. Daiichi Sankyo Company, Ltd.
  • 7.7. Eli Lilly and Co.
  • 7.8. F. Hoffman La-Roche AG
  • 7.9. Fresenius SE & Co. KGaA
  • 7.10. GlaxoSmithKline plc
  • 7.11. Johnson & Johnson Services, Inc.
  • 7.12. Lonza Group Ltd.
  • 7.13. Lupin Ltd.
  • 7.14. Merck & Co., Inc.
  • 7.15. Mylan N.V.
  • 7.16. Novartis International AG
  • 7.17. Pfizer Inc.
  • 7.18. Sanofi S.A.
  • 7.19. Sun Pharmaceutical Industries Ltd.
  • 7.20. Teva Pharmaceutical Industries Ltd.

LIST OF TABLES

  • 1. GLOBAL CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
  • 2. GLOBAL ALKYLATING MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL ANTIMETABOLITES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL ANTITUMOR ANTIBIOTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 5. GLOBAL PLANT ALKALOIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL OTHER CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 8. GLOBAL CYTOTOXIC DRUGS IN LUNG CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL CYTOTOXIC DRUGS IN BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 10. GLOBAL CYTOTOXIC DRUGS IN PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 11. GLOBAL CYTOTOXIC DRUGS IN PANCREATIC CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 12. GLOBAL CYTOTOXIC DRUGS IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 13. GLOBAL CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 14. NORTH AMERICAN CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 15. NORTH AMERICAN CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
  • 16. NORTH AMERICAN CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 17. EUROPEAN CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 18. EUROPEAN CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
  • 19. EUROPEAN CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 20. ASIA-PACIFIC CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 21. ASIA-PACIFIC CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
  • 22. ASIA-PACIFIC CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 23. REST OF THE WORLD CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
  • 24. REST OF THE WORLD CYTOTOXIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CYTOTOXIC DRUGS MARKET SHARE BY DRUG CLASS, 2019 VS 2026 (%)
  • 2. GLOBAL CYTOTOXIC DRUGS MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
  • 3. GLOBAL CYTOTOXIC DRUGS MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. US CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. ITALY CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. SPAIN CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. ROE CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. INDIA CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. CHINA CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. JAPAN CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF THE WORLD CYTOTOXIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)